HIV vaccine research has been a pillar of NIAID's scientific mission since the beginning of the HIV pandemic.

Friday, May 17, 2024 NIAID Marks HIV Vaccine Awareness Day 2024 Layout featuring a colorized 3D print of an HIV virus particle (purple with green surface proteins) and a background image that is a colorized transmission electron micrograph of HIV virus particles (purple) budding and replicating from an H9 T cell (green). Micrograph captured at the NIAID Integrated Research Facility in Fort Detrick, Maryland. Note: not to scale. Credit: NIAID Vaccines consistently transform public health, and HIV vaccine research has been a pillar of NIAID's scientific mission since the beginning of the HIV pandemic. In observance of HIV Vaccine Awareness Day (Saturday, May 18), we express our gratitude to the dedicated global community of scientists, advocates, study participants, study staff, and funders working toward a safe, effective, durable, and accessible HIV vaccine. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107